title: Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia.
abstract: Tissue edema is a facet of ischemia/reperfusion injury in many organs, polymorphonuclear leukocytes (PMN) presumably playing a contributory role. We studied the intracoronary adhesion of PMN and its effect on vascular permeability during reperfusion in isolated guinea-pig hearts. After a global ischemia of 15 min duration. PMN (10(7)) were infused into the coronary system during the first minute of reperfusion. PMN adhesion was measured as difference of applied PMN and those recovered in the effluent perfusate. Coronary permeability was assessed by measuring the rate of transudate formation (TF) on the epicardial surface, before as well as 5, 15 and 30 min after ischemia. Experiments were also performed in the presence of the NO-synthase inhibitor nitro-L-arginine (10 microM) and the ACE-inhibitor ramiprilat (2 microM), the latter known to enhance endogenous nitric oxide formation. Furthermore, the radical scavenger uric acid (0.5 mM) was applied either before and during ischemia or starting after PMN application. Ischemia/reperfusion increased coronary PMN adherence from 23 +/- 1% (basal) to 33 +/- 2%. Whereas ischemia alone did not influence TF (about 100 microliters/min during reperfusion), postischemic PMN infusion led to progressive TF. With nitro-L-arginine, PMN adhesion rose to 45 +/- 3%; TF increased to 212 +/- 30 microliters/min. In contrast, ramiprilat caused post-ischemic adhesion and TF to decline to basal values. In the presence of uric acid (UA) PMN adhesion declined to 26 +/- 2%, however, the subsequent increase in TF after withdrawal of UA was not markedly attenuated. On the other hand, infusion of UA after application of PMN caused a significant decrease of TF. The extracellular antioxidants SOD/catalase were without effect. As shown using luminol enhanced chemiluminescence. No was able to scavenge oxygen free radicals released by activated PMN. These findings indicate that enhanced PMN adhesion in reperfusion leads to an increase in coronary permeability. Scavenging of oxygen free radicals with NO or UA appears to mitigate both, postischemic PMN adhesion and PMN-induced vascular injury, even after adhesion.
authors.affiliation: Department of Physiology, University of Munich, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Kupatt
authors.forename: S
authors.initials: S
authors.lastname: Zahler
authors.forename: C
authors.initials: C
authors.lastname: Seligmann
authors.forename: P
authors.initials: P
authors.lastname: Massoudy
authors.forename: B F
authors.initials: BF
authors.lastname: Becker
authors.forename: E
authors.initials: E
authors.lastname: Gerlach
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D002374:Catalase / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects*; D002463:Cell Membrane Permeability / Q000187:drug effects; D003331:Coronary Vessels / Q000378:metabolism / Q000503:physiopathology; D005609:Free Radicals; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008163:Luminescent Measurements; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology*; D015425:Myocardial Reperfusion; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D017942:Nitric Acid / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019335:Nitroarginine / Q000494:pharmacology; D017257:Ramipril / Q000031:analogs & derivatives / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000494:pharmacology; D014527:Uric Acid / Q000494:pharmacology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D005609:Free Radicals; D019335:Nitroarginine; D014527:Uric Acid; D017942:Nitric Acid; D009240:N-Formylmethionine Leucyl-Phenylalanine; C052549:ramiprilat; D002374:Catalase; D019001:Nitric Oxide Synthase; D013482:Superoxide Dismutase; D017257:Ramipril